International Clinical Trial: Building a Predictive Model for T2DM Risk Based on Leptin/TLR4/NF-?B/Inflammatory Factor Gene Polymorphis

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133599) titled 'Building a Predictive Model for T2DM Risk Based on Leptin/TLR4/NF-?B/Inflammatory Factor Gene Polymorphis' on Sept. 29.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The First Affiliated Hospital of Guilin Medical University

Condition: Type 2 diabetes

Intervention: Control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Control group:200;Case group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=345017

Published by HT Digital Content Services ...